불임 검사 시장 : 제품별, 구입 모드별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global fertility test market size reached USD 584.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 971.7 Million by 2033, exhibiting a growth rate (CAGR) of 5.52% during 2025-2033.

Fertility tests are performed to diagnose problems that prevent couples from conceiving. They comprise blood tests, pelvic examination, semen analysis, basal body temperature (BBT) charting, post coital test, transvaginal (pelvic) ultrasound exam, hysterosalpingogram or HSG, hysteroscopy, and laparoscopy. They are reliable, valid, and assist in determining a suitable treatment. In addition, they prevent the spread of sexually transmitted infections (STIs) in the body. Fertility tests also help detect cervical cancer and abnormal cells around the cervix. As a result, they are carried out in hospitals, home care, and fertility clinics.

Fertility Test Market Trends:

The growing prevalence of diseases, such as polycystic ovary syndrome (PCOS), due to the overproduction of estrogen by the ovaries represents one of the key factors driving the market. Moreover, there is a rise in infertility rates across the globe due to lifestyle changes and increasing stress and obesity, which is caused by a lack of physical exercise and alterations in dietary pattern. This, along with the increasing awareness among the masses about the benefits of fertility tests, is propelling the growth of the market. In addition, the launch of technologically advanced products to treat infertility among the masses is positively influencing the market. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce pregnancy and ovulation test kits for centralizing all fertility-related data. This, coupled with the burgeoning healthcare industry, is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for easy-to-use fertility monitors with high accuracy. The rising utilization of artificial intelligence (AI) in sperm analysis is expected to bolster the growth of the market.

Key Market Segmentation:

Breakup by Product:

• Ovulation Prediction Kits
• Fertility Monitors
• Male Fertility Testing Products

Breakup by Mode of Purchase:

• OTC-based
• Prescription-based

Breakup by Application:

• Female Fertility Testing
• Male Fertility Testing

Breakup by End User:

• Hospitals
• Home Care Settings
• Fertility Clinics
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AdvaCare Pharma, Ava AG, Babystart Ltd. (Snowden Healthcare), Church & Dwight Co. Inc., Fairhaven Health LLC, Geratherm Medical AG, Prestige Consumer Healthcare Inc., Quidel Corporation, UEBE Medical GmbH, Valley Electronics AG and viO HealthTech Limited.

Key Questions Answered in This Report

• 1.What was the size of the global fertility test market in 2024?
• 2.What is the expected growth rate of the global fertility test market during 2025-2033?
• 3.What are the key factors driving the global fertility test market?
• 4.What has been the impact of COVID-19 on the global fertility test market?
• 5.What is the breakup of the global fertility test market based on the product?
• 6.What is the breakup of the global fertility test market based on the mode of purchase?
• 7.What is the breakup of the global fertility test market based on the application?
• 8.What is the breakup of the global fertility test market based on the end user?
• 9.What are the key regions in the global fertility test market?
• 10.Who are the key players/companies in the global fertility test market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Fertility Test Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Ovulation Prediction Kits
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Fertility Monitors
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Male Fertility Testing Products
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Mode of Purchase

• 7.1 OTC-based
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Prescription-based
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Female Fertility Testing
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Male Fertility Testing
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Home Care Settings
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Fertility Clinics
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 AdvaCare Pharma
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Ava AG
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Babystart Ltd. (Snowden Healthcare)
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Church & Dwight Co. Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Fairhaven Health LLC
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Geratherm Medical AG
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
  • 15.3.8 Prestige Consumer Healthcare Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Quidel Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 UEBE Medical GmbH
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Valley Electronics AG
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 viO HealthTech Limited
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio